Our data indicated ATF3 might be involved in the tumorigenesis, invasion and metastasis of breast cancer, and increased ATF3 expression may lead to poor prognosis, which suggests that ATF3 may play an oncogenic role in human breast tumorigenesis and development, and is useful as either a biomarker or therapeutic target of breast cancer. This evidence concerns the gene ATF3 and breast carcinoma.